Company intelligence / Profile preview

Core Scientific Creations

Ownership: Private
Development stage: Commercial

Overview

Core Scientific Creations has developed and commercialized WoundClot™, an advanced hemostatic gauze designed to rapidly stop bleeding. The product is used in emergency medicine, trauma care, surgery, and other clinical settings. Clinical results indicate improved immediate treatment capabilities and enhanced healing processes compared to traditional products.

Therapeutic areas: OtherDermatologyHematology
Modalities: Device
Industry: Consumable Medical Devices

Drug pipeline

1 asset

WoundClot

Commercial

Indications: Hemorrhage control, Surgical bleeding, Trauma

Partnerships

Not specified; distribution partners exist in various countries but no major pharma/biotech partnerships listed.

Beyond the preview

Go deeper on Core Scientific Creations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Core Scientific Creations.

Explore the full profile